Rothblatt Martine A

Chairperson &CEO | Director

2 companies

Insider Signal Score

Good

Trades Analyzed

304

12M Win Rate

53.6%

Avg 3M Return

-6.6%

Avg 12M Return

-1.6%

Rothblatt Martine A is a Chairperson &CEO at United Therapeutics Corporation with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 88 sells.

Estimated insider holdings value: $173.5M based on current market prices.

Holdings by Company

UTHRJul 30, 2026

Current Shares333.9K

Value$173.32M

Net Activity-397,910

Bought: 0Sold: 397.9K

BETAJun 11, 2026

Current Shares8.2K

Value$182.3K

Net Activity0

Bought: 0Sold: 0

Transaction History

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 30, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	9,500	$524.90	$4,986,594.10	-0.5%	-	-
Jul 29, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	9,500	$522.37	$4,962,487.78	-0.4%	-	-
Jul 28, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	9,500	$526.73	$5,003,975.56	-0.3%	-	-
Jul 27, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	9,500	$530.42	$5,038,970.75	-0.3%	-	-
Jul 24, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	9,500	$531.74	$5,051,518.52	-0.4%	-	-
Jul 14, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	9,500	$526.83	$5,004,908.72	-2.4%	-	-
Jul 9, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	8,168	$551.38	$4,503,667.91	-2.3%	-	-
Jul 8, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	9,500	$553.17	$5,255,111.50	-1.8%	-	-
Jul 6, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	9,500	$548.96	$5,215,133.38	-2.7%	-	-
Jun 25, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	9,500	$550.40	$5,228,772.56	-1.9%	-	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC